Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey
Language English Country Great Britain, England Media electronic
Document type Journal Article
PubMed
34049919
PubMed Central
PMC8166597
DOI
10.1136/bmjopen-2020-047059
PII: bmjopen-2020-047059
Knihovny.cz E-resources
- Keywords
- acute renal failure, paediatric nephrology, paediatrics,
- MeSH
- Child MeSH
- Adult MeSH
- Internet MeSH
- Nephritis, Interstitial * MeSH
- Humans MeSH
- Prospective Studies MeSH
- Cross-Sectional Studies MeSH
- Retrospective Studies MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Acute tubulointerstitial nephritis (TIN) is a significant cause of acute renal failure in paediatric and adult patients. There are no large paediatric series focusing on the aetiology, treatment and courses of acute TIN. PATIENTS, DESIGN AND SETTING: We collected retrospective clinical data from paediatric patients with acute biopsy-proven TIN by means of an online survey. Members of four professional societies were invited to participate. RESULTS: Thirty-nine physicians from 18 countries responded. 171 patients with acute TIN were included (54% female, median age 12 years). The most frequent causes were tubulointerstitial nephritis and uveitis syndrome in 31% and drug-induced TIN in 30% (the majority of these caused by non-steroidal anti-inflammatory drugs). In 28% of patients, no initiating noxae were identified (idiopathic TIN). Median estimated glomerular filtration rate (eGFR) rose significantly from 31 at time of renal biopsy to 86 mL/min/1.73 m2 3-6 months later (p<0.001). After 3-6 months, eGFR normalised in 41% of patients (eGFR ≥90 mL/min/1.73 m2), with only 3% having severe or end-stage impairment of renal function (<30 mL/min/1.73 m2). 80% of patients received corticosteroid therapy. Median eGFR after 3-6 months did not differ between steroid-treated and steroid-untreated patients. Other immunosuppressants were used in 18% (n=31) of patients, 21 of whom received mycophenolate mofetil. CONCLUSIONS: Despite different aetiologies, acute paediatric TIN had a favourable outcome overall with 88% of patients showing no or mild impairment of eGFR after 3-6 months. Prospective randomised controlled trials are needed to evaluate the efficacy of glucocorticoid treatment in paediatric patients with acute TIN.
Department of Pediatric Nephrology Aarhus University Hospital Aarhus Denmark
Department of Pediatric Nephrology Bambino Gesù Children's Hospital Roma Italy
Department of Pediatric Nephrology Connecticut Children's Medical Center Hartford Connecticut USA
Department of Pediatric Nephrology Dona Estefânia Hospital Lisboa Portugal
Department of Pediatric Nephrology Dr Behcet Uz Children Hospital Izmir Turkey
Department of Pediatric Nephrology Faculty of Medicine Ege University Izmir Turkey
Department of Pediatric Nephrology Faculty of Medicine Erciyes University Kayseri Turkey
Department of Pediatric Nephrology Faculty of Medicine Hacettepe University Ankara Turkey
Department of Pediatric Nephrology Faculty of Medicine Marmara University Istanbul Turkey
Department of Pediatric Nephrology Karolinska University Hospital Stockholm Sweden
Department of Pediatric Nephrology Meyer Children's Hospital Florence Italy
Department of Pediatric Nephrology MHH Hannover Germany
Department of Pediatric Nephrology Nationwide Children's Hospital Columbus Ohio USA
Department of Pediatric Nephrology Stony Brook Children's Hospital Stony Brook New York USA
Department of Pediatric Nephrology Temple Street Children's University Hospital Dublin Ireland
Department of Pediatric Nephrology University Children's Hospital Ljubljana Slovenia
Department of Pediatric Nephrology University Hospital of Padova Padova Italy
Department of Pediatrics 2 University Hospital Essen Essen Germany
KfH Centre of Pediatric Nephrology Clementine Kinderhospital Frankfurt am Main Germany
See more in PubMed
Clarkson MR, Giblin L, O’Connell FP, et al. . Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004;19:2778–83. 10.1093/ndt/gfh485 PubMed DOI
Goicoechea M, Rivera F, López-Gómez JM. Spanish registry of glomerulonephritis. increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2013;28:112–5. PubMed
Raghavan R, Eknoyan G. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol 2014;82:149–62. 10.5414/CN10838 PubMed DOI PMC
Verghese PS, Luckritz KE, Eddy AA. Interstitial nephritis in children. : Geary DF, Schaefer F, . Pediatric kidney disease. Berlin Heidelberg, Germany: Springer-Verlag, 2016: 1013–36.
Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol 2012;27:901–9. 10.1007/s00467-011-1992-9 PubMed DOI PMC
Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010;6:461–70. 10.1038/nrneph.2010.71 PubMed DOI
Takemura T, Okada M, Hino S, et al. . Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis 1999;34:1016–21. 10.1016/S0272-6386(99)70006-5 PubMed DOI
Vohra S, Eddy A, Levin AV, et al. . Tubulointerstitial nephritis and uveitis in children and adolescents. Four new cases and a review of the literature. Pediatr Nephrol 1999;13:426–32. 10.1007/s004670050634 PubMed DOI
Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001;60:804–17. 10.1046/j.1523-1755.2001.060002804.x PubMed DOI
Joyce E, Glasner P, Ranganathan S, et al. . Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol 2017;32:577–87. 10.1007/s00467-016-3394-5 PubMed DOI PMC
González E, Gutiérrez E, Galeano C, et al. . Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 2008;73:940–6. 10.1038/sj.ki.5002776 PubMed DOI
Buysen JG, Houthoff HJ, Krediet RT, et al. . Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant 1990;5:94–9. 10.1093/ndt/5.2.94 PubMed DOI
Galpin JE, Shinaberger JH, Stanley TM, et al. . Acute interstitial nephritis due to methicillin. Am J Med 1978;65:756–65. 10.1016/0002-9343(78)90793-3 PubMed DOI
Pusey CD, Saltissi D, Bloodworth L, et al. . Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med 1983;52:194–211. PubMed
Bhaumik SK, Kher V, Arora P, et al. . Evaluation of clinical and histological prognostic markers in drug-induced acute interstitial nephritis. Ren Fail 1996;18:97–104. 10.3109/08860229609052779 PubMed DOI
Jahnukainen T, Saarela V, Arikoski P, et al. . Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 2013;28:1253–60. 10.1007/s00467-013-2476-x PubMed DOI
Schwartz GJ, Muñoz A, Schneider MF, et al. . New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629–37. 10.1681/ASN.2008030287 PubMed DOI PMC
Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2004;19:8–11. 10.1093/ndt/gfg464 PubMed DOI
Praga M, González E. Acute interstitial nephritis. Kidney Int 2010;77:956–61. 10.1038/ki.2010.89 PubMed DOI
Schwarz A, Krause PH, Kunzendorf U, et al. . The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000;54:179–90. PubMed
Muriithi AK, Leung N, Valeri AM, et al. . Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis 2014;64:558–66. 10.1053/j.ajkd.2014.04.027 PubMed DOI
Ruffenach SJ, Siskind MS, Lien YH. Acute interstitial nephritis due to omeprazole. Am J Med 1992;93:472–3. 10.1016/0002-9343(92)90181-A PubMed DOI
Torpey N, Barker T, Ross C. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant 2004;19:1441–6. 10.1093/ndt/gfh137 PubMed DOI
Geevasinga N, Coleman PL, Webster AC, et al. . Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 2006;4:597–604. 10.1016/j.cgh.2005.11.004 PubMed DOI
Simpson IJ, Marshall MR, Pilmore H, et al. . Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology 2006;11:381–5. 10.1111/j.1440-1797.2006.00651.x PubMed DOI
Yang B, Xie Y, Guo M, et al. . Nephrotoxicity and Chinese herbal medicine. Clin J Am Soc Nephrol 2018;13:1605–11. 10.2215/CJN.11571017 PubMed DOI PMC
Petejova N, Martinek A, Zadrazil J, et al. . Acute toxic kidney injury. Ren Fail 2019;41:576–94. 10.1080/0886022X.2019.1628780 PubMed DOI PMC
Nandi M, Sarkar S. Acute kidney injury following multiple wasp stings. Pediatr Nephrol 2012;27:2315–7. 10.1007/s00467-012-2250-5 PubMed DOI
Bhatta N, Singh R, Sharma S, et al. . Acute renal failure following multiple wasp stings. Pediatr Nephrol 2005;20:1809–10. 10.1007/s00467-005-2044-0 PubMed DOI
Ambarsari CG, Sindih RM, Saraswati M, et al. . Delayed admission and management of pediatric acute kidney injury and multiple organ dysfunction syndrome in children with multiple wasp stings: a case series. Case Rep Nephrol Dial 2019;9:137–48. 10.1159/000504043 PubMed DOI PMC
Pendergraft WF, Herlitz LC, Thornley-Brown D, et al. . Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol 2014;9:1996–2005. 10.2215/CJN.00360114 PubMed DOI PMC
Jasiek M, Karras A, Le Guern V, et al. . A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome. Rheumatology 2017;56:362–70. 10.1093/rheumatology/kew376 PubMed DOI
Gwertzman R, Corey H, Roberti I. Autoimmune polyglandular syndrome type I can have significant kidney disease in children including recurrence in renal allograft - a report of two cases. Clin Nephrol 2016;85:358–62. 10.5414/CN108782 PubMed DOI
Kluger N, Kataja J, Aho H, et al. . Kidney involvement in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in a Finnish cohort. Nephrol Dial Transplant 2014;29:1750–7. 10.1093/ndt/gfu064 PubMed DOI
Wen YK, Chen ML. Microscopic polyangiitis atypically presenting with tubulointerstitial nephritis. Clin Nephrol 2006;65:356–60. 10.5414/CNP65356 PubMed DOI
Kukuy O, Livneh A, Ben-David A, et al. . Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients. J Rheumatol 2013;40:2083–7. 10.3899/jrheum.130520 PubMed DOI
Sarı İsmail, Birlik M, Kasifoğlu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol 2014;1:21–33. 10.5152/eurjrheum.2014.006 PubMed DOI PMC
Makino H, Yoshinaga Y, Yamasaki Y, et al. . Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patients. Mod Rheumatol 2002;12:148–54. 10.3109/s101650200025 PubMed DOI
Corlu L, Rioux-Leclercq N, Ganard M, et al. . Renal dysfunction in patients with direct infiltration by B-cell lymphoma. Kidney Int Rep 2019;4:688–97. 10.1016/j.ekir.2019.02.008 PubMed DOI PMC
Basak R, Wang X, Keane C, et al. . Atypical presentation of atypical haemolytic uraemic syndrome. BMJ Case Rep 2018;31:bcr2017222560. 10.1136/bcr-2017-222560 PubMed DOI PMC
Veer M, Abdulmassih R, Como J, et al. . Adenoviral nephritis in a renal transplant recipient: case report and literature review. Transpl Infect Dis 2017;19:e12716. 10.1111/tid.12716 PubMed DOI
Menter T, Mayr M, Schaub S, et al. . Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant 2013;13:1474–83. 10.1111/ajt.12218 PubMed DOI
Sumida K, Ubara Y, Hoshino J, et al. . Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol 2010;74:446–56. PubMed
Jahnukainen T, Ala-Houhala M, Karikoski R, et al. . Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol 2011;26:291–9. 10.1007/s00467-010-1698-4 PubMed DOI
Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 2001;46:195–208. 10.1016/S0039-6257(01)00261-2 PubMed DOI
Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol 2009;20:525–31. 10.1097/ICU.0b013e3283318f9a PubMed DOI
Preddie DC, Markowitz GS, Radhakrishnan J, et al. . Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol 2006;1:718–22. 10.2215/CJN.01711105 PubMed DOI